This inventor holds 1 USPTO granted patent. Top assignee: The University of British Columbia. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Mark P Lowe: Innovator in Chelating Ligands
Introduction
Mark P Lowe is a distinguished inventor based in Pontefract, GB. He has made significant contributions to the field of chemistry, particularly in the development of novel chelating ligands. His work is essential for advancements in nuclear medicine.
Latest Patents
Mark P Lowe holds a patent for "Chelating ligands having a tripodal backbone." This invention relates to innovative chelating ligands that incorporate a tripodal backbone. More specifically, it pertains to tripodal ligands that form coordination compounds with various metal ions, especially trivalent metal ions and lanthanide metal ions. These compounds are particularly useful in nuclear medicine. The patent describes a novel amine phosphinate tripodal ligand and a process involving complexing metal ions such as Technetium (Tc), Rhenium (Re), and group 13 metals like Aluminum (Al), Gallium (Ga), and Indium (In), along with rare earth elements.
Career Highlights
Mark P Lowe is affiliated with the University of British Columbia, where he continues to advance his research in the field of chelation chemistry. His work has garnered attention for its potential applications in medical technologies.
Collaborations
Mark has collaborated with Chris Orvig, a fellow researcher, to further explore the applications of his inventions in various scientific domains.
Conclusion
Mark P Lowe's innovative work in chelating ligands showcases his commitment to advancing nuclear medicine. His contributions are paving the way for new developments in the field.